AusCann Group Holding Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
27
- Latest Deal Type
-
M&A
- (Cancelled)
- Financing Rounds
-
4
- Investments
-
3
AusCann Group Holding General Information
Description
AusCann Group Holdings Ltd produces medicinal cannabis. It delivers high-quality, economical, and clinically validated cannabinoid medicinal products.
Contact Information
Website
www.auscann.com.auCorporate Office
- 1202 Hay Street
- Perth, Western Australia 6005
- Australia
Corporate Office
- 1202 Hay Street
- Perth, Western Australia 6005
- Australia
AusCann Group Holding Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
AusCann Group Holding Comparisons
Industry
Financing
Details
AusCann Group Holding Competitors (3)
One of AusCann Group Holding’s 3 competitors is Tilray Medical Australia New Zealand, a Corporation company based in Sydney, Australia.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Tilray Medical Australia New Zealand | Corporation | Sydney, Australia | ||||
| Little Green Pharma | Corporation | Wembley, Australia | ||||
| Cann Group | Corporation | Koorlong, Australia |
AusCann Group Holding Patents
AusCann Group Holding Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020900272-A0 | Cannabinoid composition and manufacturing method | Pending | 31-Jan-2020 | ||
| WO-2021151169-A1 | Cannabinoid composition and manufacturing method | Inactive | 31-Jan-2020 | ||
| AU-2020900271-A0 | Method of cannabinoid therapy | Pending | 31-Jan-2020 | ||
| WO-2021151168-A1 | Method of cannabinoid therapy | Inactive | 31-Jan-2020 | ||
| AU-2019313160-A1 | "solid self-emulsifying pharmaceutical compositions" | Inactive | 31-Jul-2018 | A61K9/4808 |
AusCann Group Holding Signals
AusCann Group Holding Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
AusCann Group Holding Investments & Acquisitions (3)
AusCann Group Holding’s most recent deal was a Merger/Acquisition with CannPal Animal Therapeutics for . The deal was made on 18-Mar-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CannPal Animal Therapeutics | 18-Mar-2021 | Merger/Acquisition | Other Consumer Non-Durables | ||
| TW Holdings | 19-Jan-2017 | Merger/Acquisition | Beverages | ||
| DayaCann | 10-Nov-2016 | Joint Venture | Pharmaceuticals |
AusCann Group Holding FAQs
-
When was AusCann Group Holding founded?
AusCann Group Holding was founded in 2013.
-
Where is AusCann Group Holding headquartered?
AusCann Group Holding is headquartered in Perth, Australia.
-
What is the size of AusCann Group Holding?
AusCann Group Holding has 27 total employees.
-
What industry is AusCann Group Holding in?
AusCann Group Holding’s primary industry is Pharmaceuticals.
-
Is AusCann Group Holding a private or public company?
AusCann Group Holding is a Private company.
-
What is AusCann Group Holding’s current revenue?
The current revenue for AusCann Group Holding is .
-
How much funding has AusCann Group Holding raised over time?
AusCann Group Holding has raised $26.1M.
-
Who are AusCann Group Holding’s investors?
Canopy Growth and TW Holdings have invested in AusCann Group Holding.
-
Who are AusCann Group Holding’s competitors?
Tilray Medical Australia New Zealand, Little Green Pharma, and Cann Group are competitors of AusCann Group Holding.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process